Hypertension Trial, Recruiting NCT06984211 Sponsor: HJN Sverige AB/Neko Health Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06984211
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who are already receiving regular care at one of the participating trial sites, or who have been specifically invited to take part.
  • People who have read the study information and signed a consent form agreeing to participate.

Who may not be able to join:

  • People who have a cognitive impairment (such as difficulty with memory, thinking, or understanding).
  • People who are not able to understand spoken or written information in Swedish or English.
  • People who have another serious illness or a terminal condition, such as a severe infection or blood poisoning, severe chronic lung disease, or cancer that has spread to other parts of the body.
  • People who are not able to give their own informed consent to participate in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Henrik Hellqvist, MD, Neko Health AB

Phone: +46703169040

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
HJN Sverige AB/Neko Health
Registry
ClinicalTrials.gov
Start date
1 February 2023
Est. completion
1 February 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Correlation between vibrometer-based PWV and ultrasound-based PWV; Assess associations between vibrometer measurements and clinical measures of increased cardiovascular risk; Assess prediction performance of increased cardiovascular risk when combining vibrometer measurements, brachial BP, ABI and ECG in prediction models; Assess performance of a multimodal risk score using data from the current study and the in parallel performed investigation "Spectrum 1" (CIV ID: CIV-22-07-039907).; Assess associations between vibrometer measurements and presence of aortic valve pathology; Assess associatio...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov